PTC THERAPEUTICS, INC. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ptc Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Ptc Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -14.9 %, a 81.6% increase year-over-year.
  • Ptc Therapeutics, Inc. annual Operating Margin for 2018 was -43.7 %, a 32.1% decline from 2017.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -14.9 +66 +81.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -22 +50.8 +69.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -39.6 +22.5 +36.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -46.9 +17.2 +26.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -80.9 -33.3 -69.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -72.8 -15.1 -26.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -62.1 +1.61 +2.53% Jan 1, 2023 Mar 31, 2023
Q4 2022 -64 +5.5 +7.91% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.6 +30.8 +39.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.7 +16.1 +21.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -63.7 +37.8 +37.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -69.5 +43.9 +38.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -73.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -102 Jan 1, 2021 Mar 31, 2021
Q4 2020 -113 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.